Interest rate changes, inflation, and volatility in the market have challenged the effectiveness of relying only on stocks and bonds.
John Imbriglia
Advertisement
John Imbriglia is the CEO of Crowd Street, a platform for self-directed private market investments with over $4 billion raised. John has over twenty years of investing and operating experience at the intersection of financial technology, the private markets, and high net worth investors.
Articles by John Imbriglia
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Medical Economics
1
Michigan pharmacist sentenced for $4M Medicare fraud scheme; ACLM publishes official position on lifestyle medicine for high-value, whole-person care; daily coffee may slow aging in serious mental illness – Morning Medical Update
2
The 10 most underused Medicare codes in primary care
3
FDA approves IsoPSA diagnostic test to improve prostate biopsy decision-making
4
Pharmacist brothers sentenced in $15M fraud scheme; noninvasive treatment for brain tumors; AI spots chronic stress in routine CT scans – Morning Medical Update
5
